• Latest Posts

AC Immune receives Milestone Payment for Alzheimer Antibody

Probiodrug bets on basic research with Harvard’s collaboration

First-in-human successful Phase I for an Alzheimer’s vaccine

Biogen is back home with its $1Bn Swiss production plant

Roche and Evotec knocked down by their Alzheimer candidate

Axovant banks on GSK’s scrapped project 


The Genomic Portrait of Iceland

Alkermes presents its new treatment of Alzheimer’s agitation

Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells